Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04158726 · ClinicalTrials.gov registry record · NA
Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia
A NA study, sponsored by Carevive Systems.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT04158726 is a NA study that has completed, run by Carevive Systems. The registered enrollment target is 47 participants.
The verdict
NCT04158726, a NA study, has completed, sponsored by Carevive Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Despite the suggestions that GA and frailty indices could be used to guide therapy selection, the ability to effectively incorporate the use of GA in older patients diagnosed with AML in a real-world clinic environment has not yet been established. Thus, in this study, the investigators seek to describe the feasibility of using this shorter GA tool, the mGA, administered via patient self-report on a touchscreen computer, as well as the real-time use and utility by clinicians and the correlation of mGA results on treatment decision-making.
Interventions
- BEHAVIORAL modified Geriatric Assessment (mGA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-04-26 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04158726
The ClinicalTrials.gov registry entry for NCT04158726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carevive Systems, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which modified Geriatric Assessment (mGA) is the first listed.
NCT04158726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04158726 about?
NCT04158726 is a clinical study titled "Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia". Despite the suggestions that GA and frailty indices could be used to guide therapy selection, the ability to effectively incorporate the use of GA in older patients diagnosed with AML in a real-world clinic environment has not yet been established. Thus, in this study, the investigators seek to desc...
What is the current status of trial NCT04158726?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-04-26. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04158726?
The interventions under investigation include: modified Geriatric Assessment (mGA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04158726?
This trial is sponsored by Carevive Systems, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.